These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1810586)

  • 21. Efficacy of nalbuphine as a parenteral analgesic for the treatment of painful episodes in children with sickle cell disease.
    Woods GM; Parson PM; Strickland DK
    J Assoc Acad Minor Phys; 1990; 1(3):90-2. PubMed ID: 2136623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks.
    Allen SE; Walsh-Kelly CM; Hennes HH
    WMJ; 2000 Apr; 99(2):60-2. PubMed ID: 10843028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Day case management of sickle pain: 3 years experience in a UK sickle cell unit.
    Wright J; Bareford D; Wright C; Augustine G; Olley K; Musamadi L; Dhanda C; Knight C
    Br J Haematol; 2004 Sep; 126(6):878-80. PubMed ID: 15352993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.
    Raphael JL; Kamdar A; Beavers MB; Mahoney DH; Mueller BU
    Pediatr Blood Cancer; 2008 Jul; 51(1):82-5. PubMed ID: 18383165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and Predictors of Bacterial infection in Febrile Children with Sickle Cell Disease.
    Morrissey BJ; Bycroft TP; Almossawi O; Wilkey OB; Daniels JG
    Hemoglobin; 2015; 39(5):316-9. PubMed ID: 26207314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
    Kourtis AP; Bansil P; Johnson C; Meikle SF; Posner SF; Jamieson DJ
    Pediatr Infect Dis J; 2007 May; 26(5):406-10. PubMed ID: 17468650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ambulatory intravenous ceftriaxone in paediatric A&E: a useful alternative to hospital admission?
    Smith JK; Alexander S; Abrahamson E
    Emerg Med J; 2011 Oct; 28(10):877-81. PubMed ID: 21325012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
    Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteremia in febrile nonneutropenic pediatric oncology patients.
    Kelly MJ; Vivier PM; Panken TM; Schwartz CL
    Pediatr Blood Cancer; 2010 Jan; 54(1):83-7. PubMed ID: 19774640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Care of the child with sickle cell disease: acute complications.
    Jakubik LD; Thompson M
    Pediatr Nurs; 2000; 26(4):373-9. PubMed ID: 12026471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient high-dose melphalan in multiple myeloma patients.
    Kassar M; Medoff E; Seropian S; Cooper DL
    Transfusion; 2007 Jan; 47(1):115-9. PubMed ID: 17207239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentation of severe anemia in pediatric patients with sickle cell anemia seen in Enugu, Nigeria.
    Juwah AI; Nlemadim A; Kaine W
    Am J Hematol; 2003 Mar; 72(3):185-91. PubMed ID: 12605390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology and health maintenance.
    Wethers DL
    Am Fam Physician; 2000 Sep; 62(5):1013-20, 1027-8. PubMed ID: 10997528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial meningitis in children in southern Ghana.
    Commey JO; Rodrigues OP; Akita FA; Newman M
    East Afr Med J; 1994 Feb; 71(2):113-7. PubMed ID: 7925039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftriaxone as a single agent in empirical therapy of unexplained fever in granulocytopenic children with solid tumors.
    Bartolozzi S; Clerico A; Properzi E; Minori A; Castello MA
    J Chemother; 1997 Jun; 9(3):227-31. PubMed ID: 9210007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fever in young children with sickle cell disease.
    McIntosh S; Rooks Y; Ritchey AK; Pearson HA
    J Pediatr; 1980 Feb; 96(2):199-204. PubMed ID: 7351579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient management of febrile illness in infants and young children with sickle cell anemia.
    Rogers ZR; Morrison RA; Vedro DA; Buchanan GR
    J Pediatr; 1990 Nov; 117(5):736-9. PubMed ID: 2121947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.